Aurora Cannabis Inc. (ACB.TO)
| Previous close | 9.39 |
| Open | 9.29 |
| Bid | 8.86 x 0 |
| Ask | 8.87 x 0 |
| Day's range | 8.65 - 9.44 |
| 52-week range | 3.84 - 15.50 |
| Volume | |
| Avg. volume | 2,165,899 |
| Market cap | 512.124M |
| Beta (5Y monthly) | 2.65 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- PR Newswire
Aurora Marks First Shipment of Medical Cannabis to the New Zealand Market
Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) the Canadian based leading global medical cannabis company, is proud to announce the arrival of Aurora branded medical cannabis products to the New Zealand market. This new line of premium dried flowers represents a significant milestone in medical cannabis accessibility in New Zealand, an emerging market poised for growth.
- PR Newswire
Aurora Improves Offerings in Australia with New Range of Premium Dried Flower Products
Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) – the Canadian based leading global medical cannabis company, in conjunction with MedReleaf Australia, is pleased to announce the expansion of its portfolio with the introduction of a new range of premium dried cannabis flower products. Now available for doctors to prescribe to patients in Australia, the new products developed by Aurora and manufactured at its EU-GMP and TGA-GMP certified facility, will be distributed by MedReleaf Australia, a premie
- PR Newswire
Aurora Cannabis Commends Germany's Landmark Legalization Achievement
Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) – a Canadian based leading global medical cannabis company, applauds the German government's final endorsement of cannabis legalization, marking a significant step forward in bolstering patient access to medical cannabis with the official passing of the Cannabis Act.
